Hepatitis C among noninjecting drug users: a report
- PMID: 11346280
- DOI: 10.1081/ja-100102640
Hepatitis C among noninjecting drug users: a report
Abstract
Objectives: This report documents the prevalence of hepatitis C virus (HCV) infection among self-reported noninjecting drug users recruited from two New York City neighborhoods.
Methods: Participants were recruited in separate studies from East Harlem and the Lower East Side of Manhattan and were administered structured questionnaires and tested for HCV.
Results: HCV prevalence rates among those reporting no history of injecting drugs ranged from 5% to 29%, according to age, gender, and study location.
Conclusions: Our results suggest that more research is needed to elucidate potential noninjecting routes of HCV transmission among drug users. Moreover, policies that rely predominantly on injector status as the only drug-related risk factor for HCV screening need to be reassessed in light of these findings.
Comment in
-
Transmission of hepatitis C--are noninjecting cocaine users at risk?Subst Use Misuse. 2002 Mar;37(4):573-5. Subst Use Misuse. 2002. PMID: 12064440 No abstract available.
Similar articles
-
Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.J Infect Dis. 2007 Apr 1;195(7):1052-61. doi: 10.1086/512081. Epub 2007 Feb 23. J Infect Dis. 2007. PMID: 17330797
-
Hepatitis C virus infection among noninjecting drug users in New York City.J Med Virol. 2003 Jul;70(3):387-90. doi: 10.1002/jmv.10407. J Med Virol. 2003. PMID: 12767001
-
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.Am J Public Health. 2001 Jan;91(1):23-30. doi: 10.2105/ajph.91.1.23. Am J Public Health. 2001. PMID: 11189819 Free PMC article.
-
A potential hidden source of hepatitis C infection among noninjecting drug users.J Psychoactive Drugs. 2003 Oct-Dec;35(4):455-60. doi: 10.1080/02791072.2003.10400492. J Psychoactive Drugs. 2003. PMID: 14986874 Review.
-
Correlates of hepatitis C virus infections among injection drug users.Medicine (Baltimore). 1995 Jul;74(4):212-20. doi: 10.1097/00005792-199507000-00005. Medicine (Baltimore). 1995. PMID: 7623656 Review.
Cited by
-
Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users.Harm Reduct J. 2006 Jan 10;3:1. doi: 10.1186/1477-7517-3-1. Harm Reduct J. 2006. PMID: 16403229 Free PMC article.
-
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.BMC Infect Dis. 2007 Dec 10;7:145. doi: 10.1186/1471-2334-7-145. BMC Infect Dis. 2007. PMID: 18070362 Free PMC article.
-
Non-injection drug use and Hepatitis C Virus: a systematic review.Drug Alcohol Depend. 2007 Jun 15;89(1):1-12. doi: 10.1016/j.drugalcdep.2006.11.014. Epub 2006 Dec 15. Drug Alcohol Depend. 2007. PMID: 17174481 Free PMC article.
-
A Training Model for Implementing Hepatitis Prevention Services in Substance Use Disorder Clinics: A Qualitative Evaluation.J Gen Intern Med. 2015 Aug;30(8):1215-21. doi: 10.1007/s11606-015-3317-3. J Gen Intern Med. 2015. PMID: 25903992 Free PMC article. No abstract available.
-
Education and equipment for people who smoke crack cocaine in Canada: progress and limits.Harm Reduct J. 2017 May 12;14(1):17. doi: 10.1186/s12954-017-0144-3. Harm Reduct J. 2017. PMID: 28494810 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
